Clinical trials in the surgical management of congestive heart failure: Surgical ventricular restoration and autologous skeletal myoblast and stem cell cardiomyoplasty

Patrick I. McConnell, Robert E. Michler

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Despite continued advances in medical and surgical approaches for patients with ischemic cardiomyopathy, congestive heart failure (CHF) remains a growing cause of morbidity and mortality. Historically, surgical options for end-stage CHF have been limited. However, there are several surgical therapies now under clinical investigation that appear promising in the effort to reverse or restore the remodeled left ventricle. This review will focus on early but current clinical studies examining surgical ventricular restoration and autologous skeletal myoblast and stem cell transplantation. Although these emerging therapeutic options remain in the early stages of study and development, they hold promise in providing options to those patients with end-stage CHF.

Original languageEnglish (US)
Pages (from-to)48-60
Number of pages13
JournalCardiology
Volume101
Issue number1-3
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Cardiomyoplasty
Skeletal Myoblasts
Stem Cells
Heart Failure
Clinical Trials
Stem Cell Transplantation
Cardiomyopathies
Heart Ventricles
Morbidity
Mortality
Therapeutics

Keywords

  • Autologous skeletal myoblast transplantation
  • Congestive heart failure
  • Left ventricular dysfunction
  • Surgical ventricular restoration
  • Ventricular remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{06c57ae1ab1c48f58a6bdff520a04c25,
title = "Clinical trials in the surgical management of congestive heart failure: Surgical ventricular restoration and autologous skeletal myoblast and stem cell cardiomyoplasty",
abstract = "Despite continued advances in medical and surgical approaches for patients with ischemic cardiomyopathy, congestive heart failure (CHF) remains a growing cause of morbidity and mortality. Historically, surgical options for end-stage CHF have been limited. However, there are several surgical therapies now under clinical investigation that appear promising in the effort to reverse or restore the remodeled left ventricle. This review will focus on early but current clinical studies examining surgical ventricular restoration and autologous skeletal myoblast and stem cell transplantation. Although these emerging therapeutic options remain in the early stages of study and development, they hold promise in providing options to those patients with end-stage CHF.",
keywords = "Autologous skeletal myoblast transplantation, Congestive heart failure, Left ventricular dysfunction, Surgical ventricular restoration, Ventricular remodeling",
author = "McConnell, {Patrick I.} and Michler, {Robert E.}",
year = "2004",
doi = "10.1159/000075985",
language = "English (US)",
volume = "101",
pages = "48--60",
journal = "Cardiology (Switzerland)",
issn = "0008-6312",
publisher = "S. Karger AG",
number = "1-3",

}

TY - JOUR

T1 - Clinical trials in the surgical management of congestive heart failure

T2 - Surgical ventricular restoration and autologous skeletal myoblast and stem cell cardiomyoplasty

AU - McConnell, Patrick I.

AU - Michler, Robert E.

PY - 2004

Y1 - 2004

N2 - Despite continued advances in medical and surgical approaches for patients with ischemic cardiomyopathy, congestive heart failure (CHF) remains a growing cause of morbidity and mortality. Historically, surgical options for end-stage CHF have been limited. However, there are several surgical therapies now under clinical investigation that appear promising in the effort to reverse or restore the remodeled left ventricle. This review will focus on early but current clinical studies examining surgical ventricular restoration and autologous skeletal myoblast and stem cell transplantation. Although these emerging therapeutic options remain in the early stages of study and development, they hold promise in providing options to those patients with end-stage CHF.

AB - Despite continued advances in medical and surgical approaches for patients with ischemic cardiomyopathy, congestive heart failure (CHF) remains a growing cause of morbidity and mortality. Historically, surgical options for end-stage CHF have been limited. However, there are several surgical therapies now under clinical investigation that appear promising in the effort to reverse or restore the remodeled left ventricle. This review will focus on early but current clinical studies examining surgical ventricular restoration and autologous skeletal myoblast and stem cell transplantation. Although these emerging therapeutic options remain in the early stages of study and development, they hold promise in providing options to those patients with end-stage CHF.

KW - Autologous skeletal myoblast transplantation

KW - Congestive heart failure

KW - Left ventricular dysfunction

KW - Surgical ventricular restoration

KW - Ventricular remodeling

UR - http://www.scopus.com/inward/record.url?scp=1542614579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542614579&partnerID=8YFLogxK

U2 - 10.1159/000075985

DO - 10.1159/000075985

M3 - Article

C2 - 14988626

AN - SCOPUS:1542614579

VL - 101

SP - 48

EP - 60

JO - Cardiology (Switzerland)

JF - Cardiology (Switzerland)

SN - 0008-6312

IS - 1-3

ER -